These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 8761140

  • 1. [Profile of p53 mutations and abnormal expression of P53 protein in 2 forms of esophageal cancer].
    Muzeau F, Fléjou JF, Potet F, Belghiti J, Thomas G, Hamelin R.
    Gastroenterol Clin Biol; 1996; 20(5):430-7. PubMed ID: 8761140
    [Abstract] [Full Text] [Related]

  • 2. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS, Osterheld MC, Bosman FT, Benhattar J, Fontolliet C.
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [Abstract] [Full Text] [Related]

  • 3. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.
    Schneider PM, Stoeltzing O, Roth JA, Hoelscher AH, Wegerer S, Mizumoto S, Becker K, Dittler HJ, Fink U, Siewert JR.
    Clin Cancer Res; 2000 Aug; 6(8):3153-8. PubMed ID: 10955797
    [Abstract] [Full Text] [Related]

  • 4. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas.
    Wagata T, Shibagaki I, Imamura M, Shimada Y, Toguchida J, Yandell DW, Ikenaga M, Tobe T, Ishizaki K.
    Cancer Res; 1993 Feb 15; 53(4):846-50. PubMed ID: 8094033
    [Abstract] [Full Text] [Related]

  • 5. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
    Gao H, Wang LD, Zhou Q, Hong JY, Huang TY, Yang CS.
    Cancer Res; 1994 Aug 15; 54(16):4342-6. PubMed ID: 8044781
    [Abstract] [Full Text] [Related]

  • 6. p53 gene mutations in Barrett's epithelium and esophageal cancer.
    Casson AG, Mukhopadhyay T, Cleary KR, Ro JY, Levin B, Roth JA.
    Cancer Res; 1991 Aug 15; 51(16):4495-9. PubMed ID: 1868473
    [Abstract] [Full Text] [Related]

  • 7. p53 mutations in esophageal tumors from a high incidence area of China in relation to patient diet and smoking history.
    Bennett WP, von Brevern MC, Zhu SM, Bartsch H, Muehlbauer KR, Hollstein MC.
    Cancer Epidemiol Biomarkers Prev; 1997 Nov 15; 6(11):963-6. PubMed ID: 9367071
    [Abstract] [Full Text] [Related]

  • 8. Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study.
    Casson AG, Evans SC, Gillis A, Porter GA, Veugelers P, Darnton SJ, Guernsey DL, Hainaut P.
    J Thorac Cardiovasc Surg; 2003 May 15; 125(5):1121-31. PubMed ID: 12771886
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas.
    Fléjou JF, Muzeau F, Potet F, Lepelletier F, Fékété F, Hénin D.
    Pathol Res Pract; 1994 Dec 15; 190(12):1141-8. PubMed ID: 7540752
    [Abstract] [Full Text] [Related]

  • 11. p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China.
    Lung ML, Chan WC, Zong YS, Tang CM, Fok CL, Wong KT, Chan LK, Lau KW.
    Cancer Epidemiol Biomarkers Prev; 1996 Apr 15; 5(4):277-84. PubMed ID: 8722219
    [Abstract] [Full Text] [Related]

  • 12. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
    Kawasaki H, Ogura T, Yokose T, Nagai K, Nishiwaki Y, Esumi H.
    Hum Pathol; 2001 Oct 15; 32(10):1043-9. PubMed ID: 11679937
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Unusual profile and high prevalence of p53 mutations in esophageal squamous cell carcinomas from northern Iran.
    Biramijamal F, Allameh A, Mirbod P, Groene HJ, Koomagi R, Hollstein M.
    Cancer Res; 2001 Apr 01; 61(7):3119-23. PubMed ID: 11306496
    [Abstract] [Full Text] [Related]

  • 15. p53 immunoreactivity in Barrett's metaplasia, dysplasia, and adenocarcinoma--a case report.
    Kimura H, Konishi K, Kaji M, Maeda K, Yabushita K, Miwa A.
    Hepatogastroenterology; 2001 Apr 01; 48(42):1662-4. PubMed ID: 11813596
    [Abstract] [Full Text] [Related]

  • 16. [Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus].
    Schneider PM, Hölscher AH, Wegerer S, König U, Becker K, Siewert JR.
    Langenbecks Arch Chir Suppl Kongressbd; 1998 Apr 01; 115(Suppl I):495-9. PubMed ID: 14518305
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Detection of p53 gene mutations in human esophageal squamous cell carcinomas using a p53 yeast functional assay: possible difference in esophageal carcinogenesis between the young and the elderly group.
    Okuda E, Osugi H, Morimura K, Takada N, Takemura M, Fukushima S, Higashino M, Kinoshita H.
    Clin Cancer Res; 2001 Mar 01; 7(3):600-6. PubMed ID: 11297255
    [Abstract] [Full Text] [Related]

  • 20. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
    Goan YG, Hsu HK, Chang HC, Chou YP, Chiang KH, Cheng JT.
    Ann Thorac Surg; 2005 Sep 01; 80(3):1007-16. PubMed ID: 16122475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.